US 11034739
Ligand-guided phagocytosis based therapy for treatment of Alzheimer's disease and other neurodegenerative diseases
granted A61KA61K38/00A61P
Quick answer
US patent 11034739 (Ligand-guided phagocytosis based therapy for treatment of Alzheimer's disease and other neurodegenerative diseases) held by The Board of Regents of the Nevada System of Higher Education on Behalf of the University of Nevada expires Mon Jun 10 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the Nevada System of Higher Education on Behalf of the University of Nevada
- Grant date
- Tue Jun 15 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 10 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 15
- CPC classes
- A61K, A61K38/00, A61P, A61P25/28